Exousia Bio, Inc. (LMMY)

Market Cap	8.48M +505.3%
Revenue (ttm)	n/a -67.4%
Net Income	-80.16K
EPS	-0.01
Shares Out	52.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	0.4000
Previous Close	0.1615
Day's Range	0.1200 - 0.4000
52-Week Range	0.1200 - 0.9400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Exousia Bio

Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company’s platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg...

• Industry: Education & Training Services
• Sector: Consumer Staples
• Founded: 2022
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: LMMY

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error